Comparing 19 vendors in Pen Needles across 0 criteria.
1 INTRODUCTION
1.1 Study Objectives
1.2 Market Definition
1.2.1 Inclusions & Exclusions
1.2.2 Market Segmentation
1.2.3 Years Considered
1.2.4 Currency Considered
1.3 Limitations
1.4 Stakeholders
1.5 Summary of Changes
2 MARKET OVERVIEW
2.1 Introduction
2.2 Market Dynamics
2.2.1 Drivers
2.2.1.1 Rising incidence of chronic diseases
2.2.1.2 Favorable reimbursements in certain countries
2.2.1.3 Growing adoption of self-administration
2.2.1.4 Decreasing prices of insulin formulations
2.2.2 Restraints
2.2.2.1 Alternative methods of drug delivery
2.2.2.2 Poor reimbursement scenario in emerging markets
2.2.2.3 Needle anxiety
2.2.3 Opportunities
2.2.3.1 Growing preference for biosimilar drugs
2.2.3.2 Emerging economies to offer highgrowth potential
2.2.3.3 Rising healthcare expenditure on diabetes
2.2.3.4 Implementation of regulations for safety pen needles
2.2.4 Challenges
2.2.4.1 ReUse of pen needles
2.2.4.2 MisUse of injection pens
2.3 Industry Trends
2.3.1 Growing Preference for Safety-Engineered Pen Needles
2.3.2 Rising Adoption of Shorter and Ultra-Thin Needles
2.4 Reimbursement Scenario
2.5 Value Chain Analysis
2.6 Ecosystem Analysis
2.7 Porter’s Five Forces Analysis
2.7.1 Intensity of Competitive Rivalry
2.7.2 Bargaining Power of Suppliers
2.7.3 Bargaining Power of Buyers
2.7.4 Threat of Substitutes
2.7.5 Threat of New Entrants
2.8 Supply Chain Analysis
2.9 Trade Analysis
2.9.1 Trade Analysis of Needles, Catheters, and Cannulae Used in
Medical, Surgical, Dental, or Veterinary Sciences (HS Code 901839)
2.9.2 Export Data (HS Code 901839), 2019–2023
2.9.3 Import Data (HS Code 901839), 2019–2023
2.10 Patent Analysis
2.10.1 Patent Publication Trends for Pen Needles
2.10.2 Insights: Jurisdiction and Top Applicant Analysis
3 COMPETITIVE LANDSCAPE
3.1 Introduction
3.2 Key Player Strategies/Right to Win
3.2.1 Overview of Strategies Adopted By Key Players in Pen Needles
Market
3.3 Revenue Analysis, 2019–2023
3.4 Market Share Analysis, 2023
3.5 Company Evaluation Matrix: Key Players, 2023
3.5.1 Stars
3.5.2 Emerging Leaders
3.5.3 Pervasive Players
3.5.4 Participants
3.5.5 Company Footprint: Key Players, 2023
3.5.5.1 Company footprint
3.5.5.2 Region footprint
3.5.5.3 Type footprint
3.5.5.4 Length footprint
3.5.5.5 Application footprint
3.6 Company Valuation & Financial Metrics
3.7 Competitive Scenario
3.7.1 Product Launches & Approvals
3.7.2 Deals
3.7.3 Expansions
3.8 Brand/Product Comparison
3.9 R&D Expenditure of Key Players
4 COMPANY PROFILES
4.1 EMBECTA CORP.
4.1.1 Business overview
4.1.2 Products/Solutions/Services offered
4.1.3 Recent developments
4.2 NOVO NORDISK A/S
4.2.1 Business overview
4.2.2 Products/Solutions/Services offered
4.2.3 Recent developments
4.3 B. BRAUN SE
4.3.1 Business overview
4.3.2 Products/Solutions/Services offered
4.3.3 Recent developments
4.4 YPSOMED
4.4.1 Business overview
4.4.2 Products/Solutions/Services offered
4.4.3 Recent developments
4.5 TERUMO CORPORATION
4.5.1 Business overview
4.5.2 Products/Solutions/Services offered
4.5.3 Recent developments
4.6 NIPRO
4.6.1 Business overview
4.6.2 Products/Solutions/Services offered
4.6.3 Recent developments
4.7 OWEN MUMFORD
4.7.1 Business overview
4.7.2 Products/Solutions/Services offered
4.7.3 Recent developments
4.8 ARKRAY, INC.
4.8.1 Business overview
4.8.2 Products/Solutions/Services offered
4.8.3 Recent developments
4.9 ULTIMED, INC.
4.9.1 Business overview
4.9.2 Products/Solutions/Services offered
4.9.3 Recent developments
4.10 HINDUSTAN SYRINGES & MEDICAL DEVICES LTD.
4.10.1 Business overview
4.10.2 Products/Solutions/Services offered
4.10.3 Recent developments
4.11 MONTMÉD
4.11.1 Business overview
4.11.2 Products/Solutions/Services offered
4.11.3 Recent developments
4.12 HTL-STREFA
4.12.1 Business overview
4.12.2 Products/Solutions/Services offered
4.12.3 Recent developments
4.13 ALLISON MEDICAL, INC.
4.13.1 Business overview
4.13.2 Products/Solutions/Services offered
4.13.3 Recent developments
4.14 GLUCORX LIMITED
4.14.1 Business overview
4.14.2 Products/Solutions/Services offered
4.14.3 Recent developments
4.15 BERPU MEDICAL TECHNOLOGY CO., LTD.
4.15.1 Business overview
4.15.2 Products/Solutions/Services offered
4.15.3 Recent developments
4.16 VAN HEEK MEDICAL
4.16.1 Business overview
4.16.2 Products/Solutions/Services offered
4.16.3 Recent developments
4.17 SIMPLE DIAGNOSTICS
4.17.1 Business overview
4.17.2 Products/Solutions/Services offered
4.17.3 Recent developments
4.18 IYON HEALTH MEDICAL
4.18.1 Business overview
4.18.2 Products/Solutions/Services offered
4.18.3 Recent developments
4.19 LINKS MEDICAL PRODUCTS INC.
4.19.1 Business overview
4.19.2 Products/Solutions/Services offered
4.19.3 Recent developments
4.20 MHC MEDICAL PRODUCTS, LLC
4.20.1 Business overview
4.20.2 Products/Solutions/Services offered
4.20.3 Recent developments
4.21 ADVACARE PHARMA
4.21.1 Business overview
4.21.2 Products/Solutions/Services offered
4.21.3 Recent developments
4.22 ARTSANA S.P.A.
4.22.1 Business overview
4.22.2 Products/Solutions/Services offered
4.22.3 Recent developments
4.23 PROMISEMED MEDICAL DEVICES, INC.
4.23.1 Business overview
4.23.2 Products/Solutions/Services offered
4.23.3 Recent developments
4.24 TRIVIDIA HEALTH, INC.
4.24.1 Business overview
4.24.2 Products/Solutions/Services offered
4.24.3 Recent developments
4.25 VOGT MEDICAL VERTRIEB GMBH
4.25.1 Business overview
4.25.2 Products/Solutions/Services offered
4.25.3 Recent developments